Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

IONS

IONIS PHARMACEUTICALS INC

Tremor tracks 3 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

  • 2 insiders sold shares within a monthSince Oct 16, 2026+7.8

Trials

  • IONSIonis Pharmaceuticals, Inc.
    18Calm

    A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

    FinishedPhase 250 patientsMain results: Jun 26, 2025
  • IONSIonis Pharmaceuticals, Inc.
    18Calm

    GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

    FinishedPhase 2332 patientsMain results: Apr 18, 2024
  • IONSIonis Pharmaceuticals, Inc.
    8Calm

    FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

    Running, no new patientsPhase 389 patientsMain results: Jun 17, 2026

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

21 sales (2 not pre-planned) · 2 purchases

  • Devers Shannon L.EVP, Chief Human Resources Ofc · Oct 16, 2026Sold 1,357 sharesabout $59 thousand · not pre-planned
  • Swayze EricEVP Research · Oct 16, 2026Sold 53 sharesabout $2 thousand · not pre-planned
  • Hayden Michael RBoard member · Jul 31, 2026Bought 5,000 sharesabout $258 thousand ·
  • Hayden Michael RBoard member · Jul 30, 2026Bought 15,000 sharesabout $801 thousand ·
  • BENNETT C FRANKEVP, Chief Scientific Officer · Jul 7, 2026Sold 5,536 sharesabout $463 thousand · pre-planned
  • BENNETT C FRANKEVP, Chief Scientific Officer · Jul 7, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 9, 2026
  • Shared quarterly resultsNews report (8-K)Nov 9, 2026
  • Shared information with investors; Other newsNews report (8-K)Oct 23, 2026
  • Shared information with investors; Other newsNews report (8-K)Oct 21, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 23, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Sold 15,000 sharesabout $1.3 million · pre-planned
  • Diaz Allene M.Board member · Jul 7, 2026Sold 10,111 sharesabout $864 thousand · pre-planned
  • Kordasiewicz Holly B.EVP, Chief Development Officer · Jul 7, 2026Sold 362 sharesabout $31 thousand · pre-planned
  • KLEIN JOSEPH IIIBoard member · Jul 1, 2026Sold 99 sharesabout $8 thousand · pre-planned
  • KLEIN JOSEPH IIIBoard member · Jul 1, 2026Sold 11,419 sharesabout $903 thousand · pre-planned
  • Baroldi JosephEVP, Chief Business Officer · Jun 26, 2026Sold 5,635 sharesabout $452 thousand · pre-planned
  • O'NEIL PATRICK R.EVP CLO & General Counsel · Jun 26, 2026Sold 3,069 sharesabout $246 thousand · pre-planned
  • Schneider EugeneEVP, Chf Clinical Develop Ofcr · Jun 26, 2026Sold 26,000 sharesabout $2.1 million · pre-planned
  • Monia Brett PChief Executive Officer · Jun 26, 2026Sold 50,000 sharesabout $4.0 million · pre-planned
  • Monia Brett PChief Executive Officer · Jun 25, 2026Sold 21,072 sharesabout $1.7 million · pre-planned
  • Swayze EricEVP Research · Jun 25, 2026Sold 10,602 sharesabout $839 thousand · pre-planned
  • Monia Brett PChief Executive Officer · Jun 24, 2026Sold 14,565 sharesabout $1.1 million · pre-planned
  • BERTHELSEN SPENCER RBoard member · Jun 15, 2026Sold 8,000 sharesabout $588 thousand · pre-planned
  • Kordasiewicz Holly B.EVP, Chief Development Officer · Jun 12, 2026Sold 41,004 sharesabout $3.0 million · pre-planned
  • Kordasiewicz Holly B.EVP, Chief Development Officer · Jun 12, 2026Sold 19,842 sharesabout $1.5 million · pre-planned
  • BERTHELSEN SPENCER RBoard member · Jun 1, 2026Sold 8,000 sharesabout $605 thousand · pre-planned
  • Monia Brett PChief Executive Officer · May 14, 2026Sold 3,220 sharesabout $253 thousand · pre-planned
  • Monia Brett PChief Executive Officer · May 13, 2026Sold 1,316 sharesabout $103 thousand · pre-planned
    • Shared information with investors; Other newsNews report (8-K)
    Sep 4, 2026
  • Shared information with investors; Other newsNews report (8-K)Sep 4, 2026
  • Quarterly reportQuarterly report (10-Q)Jul 29, 2026
  • Shared quarterly resultsNews report (8-K)Jul 29, 2026
  • Shared information with investorsNews report (8-K)Jul 10, 2026
  • Shared information with investors; Other newsNews report (8-K)Jul 9, 2026
  • Shared information with investors; Other newsNews report (8-K)Jun 24, 2026
  • Other newsNews report (8-K)Jun 12, 2026
  • An executive or board member joined or left; Shared information with investorsNews report (8-K)Jun 8, 2026
  • Shared information with investors; Other newsNews report (8-K)May 28, 2026